Innovating with
Extracellular vesicles

Leading the future of biotechnology through hiPSC-derived extracellular vesicles, advanced diagnostics, and scalable bioprocessing solutions.

Our Core Technologies

Pioneering the next generation of exosome-based therapeutics through innovative hiPSC technologies

Revolutionary extracellular vesicles derived from human induced pluripotent stem cells for therapeutic applications.

Precisely engineered extracellular vesicles with enhanced targeting capabilities and therapeutic payload delivery systems.

Proprietary formulation providing controlled and sustained release of therapeutic extracellular vesicles.

In Vitro Diagnostic products for infectious, metabolic, reproductive, and cancer biomarker detection.

Scalable production systems for exosome manufacturing and quality assurance

Traditional monolayer cell culture systems optimized for high-yield exosome production with consistent quality metrics and reproducible results.

Advanced three-dimensional cell culture platforms that mimic physiological conditions for enhanced exosome production and bioactivity.

Industrial-scale bioreactor systems with GMP compliance for commercial exosome manufacturing and pharmaceutical-grade production.

Partner with Genefront Inc for cutting-edge exosome technologies and diagnostic solutions. Let's innovate together for a healthier future.